US Pharmacopeia's Medicine Supply Map reveals that 14 out of 20 essential cancer drugs have over 40% of their production concentrated in a single facility. The Biden administration has added pharmaceuticals and active pharmaceutical ingredients to its critical product sectors list, as drug shortages pose a threat to military readiness. Over 60% of critical chemical supply for pharmaceuticals is sourced from India and China, while only 10% is produced in the US. Experts suggest near-shoring pharmaceutical sourcing would reduce supply chain risks. Reliability and availability are crucial factors for life-saving medicines.
Frequently Asked Questions (FAQ) - Medicine Supply Chain Vulnerabilities - Wilson Center
FAQ 1: What are medicine supply chain vulnerabilities?
Answer: Medicine supply chain vulnerabilities refer to weaknesses within the process of producing and delivering medical supplies and pharmaceuticals. These can include problems with sourcing raw materials, manufacturing, distribution, quality control, and regulatory issues that can lead to shortages or disruptions in the availability of essential medicines.
FAQ 2: Who discussed medicine supply chain vulnerabilities at the Wilson Center?
Answer: Ambassador Mark Green has provided insights and analysis on medicine supply chain vulnerabilities at the Wilson Center, as indicated by the content of the search results.
FAQ 3: Where can I find more information about medicine supply chain vulnerabilities?
Answer: To learn more about medicine supply chain vulnerabilities, you can read the blog posts and analysis on the Wilson Center's website and look for related content under their Global Health issues.
FAQ 4: How does the Wilson Center contribute to the discussion on supply chain vulnerabilities?
Answer: The Wilson Center provides a platform for experts to offer their insights and holds events that explore the various aspects of supply chain vulnerabilities. Experts at the Wilson Center analyze and discuss potential risks and strategies to strengthen supply chains against disruptions.
FAQ 5: Are there any specific regions or topics related to medicine supply chain vulnerabilities that the Wilson Center focuses on?
Answer: The Wilson Center covers a broad range of topics related to global health, including medicine supply chain vulnerabilities. While specific regional focuses may vary, topics like climate migration, strategic competition, and technology innovation can intersect with medicine supply chain discussions. For instance, an episode of Plaza Central discusses Taiwan's 'Medical Diplomacy' in Latin America here.
FAQ 6: Does the Wilson Center provide any resources on technology and supply chain vulnerabilities?
Answer: Yes, the Wilson Center offers resources and analysis on how emerging technologies, such as 5G, can impact supply chains and potentially introduce new vulnerabilities. Information on this topic can be found on their 5G Explained page here.
Please note that while these FAQs are generated based on available search results, some details such as specific content and depth of analysis may only be accessible by directly visiting the Wilson Center's website or reading the full analysis provided by their experts.